Status:
COMPLETED
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Lead Sponsor:
Heidelberg University
Collaborating Sponsors:
Verein für Krebsforschung, Arlesheim, Swizzerland
Weleda AG, D-73525 Schwäbisch Gmünd
Conditions:
Metastatic Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this feasibility study is to identify appropriate surrogate parameters for a randomized study to examine the efficacy of a complementary therapy with an extract of viscum album (Iscador...
Detailed Description
The study consists of three parts. Part 1 is a prospective non-randomized feasibility study in patients with breast cancer after primary surgery during chemotherapy or endocrine therapy comparing bloo...
Eligibility Criteria
Inclusion
- breast cancer
- desire for additional therapy with mistletoe extracts
Exclusion
- contraindication for a therapy with mistletoe extracts(allergy, tuberculosis, hyperthyreosis, acute infectious disease, intracranial pressure in case of tumors or metastasis)
- current medication with glucocorticoids or other immunosuppressive therapies
- other concomitant complementary therapies
- prior therapy with mistletoe extracts \> 2 years or during the last 6 months
- karnofsky-Index \<60
Key Trial Info
Start Date :
May 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00176046
Start Date
May 1 1999
End Date
July 1 2009
Last Update
May 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Complementary and Integrative Medicine
Heidelberg, Baden-Wurttemberg, Germany, D-69120